News

Dow, S&P 500 end lower; Eli Lilly shares fall after drug data
The Dow and S&P 500 eased on Thursday, as shares of Eli Lilly dropped after data from its oral weight loss drug disappointed, ...
Eli Lilly happy with weight loss pill performance as drugmaker races to be the first to market
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...
Eli Lilly Shares Plummet 14% Toward Worst Day In 25 Years—Here’s Why It’s Down
Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...
Lilly pill cuts body weight by 12.4% in trial, lagging Novo's Wegovy injection
Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight in a late-stage ...
Experimental GLP-1 pill helped people with obesity lose weight, Eli Lilly says
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...
Stocks to Watch Thursday: Eli Lilly, Firefly, DoorDash, TSMC
The iPhone maker's shares [rallied for a second day]( ...
Stock Movers: Paycom, Fortinet, Lilly
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Lilly's GLP-1 pill cuts body weight by 12.4% in trial, lagging Novo's injection
Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight after 72 weeks in ...
Eli Lilly Q2 Earnings: Ignore Oral Weight Loss Bombshell, This Is A Buy The Dip Moment
Eli Lilly stock dips despite strong Q2 results. Read my insights on obesity drug market dominance and why this selloff in LLY ...